• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对部分高分化甲状腺癌患者行峡部切除术。

Isthmusectomy in selected patients with well-differentiated thyroid carcinoma.

作者信息

Park Hakyoung, Harries Victoria, McGill Marlena R, Ganly Ian, Shah Jatin P

机构信息

Department of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, New York.

Department of Surgery, InJe University Busan Paik Hospital, Busan, South Korea.

出版信息

Head Neck. 2020 Jan;42(1):43-49. doi: 10.1002/hed.25968. Epub 2019 Oct 7.

DOI:10.1002/hed.25968
PMID:31589005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7485011/
Abstract

BACKGROUND

Isthmusectomy in the treatment of well-differentiated thyroid carcinoma (WDTC) is controversial. In this study, we analyze the outcomes of WDTC managed by isthmusectomy alone.

METHODS

Forty-three patients treated with isthmusectomy alone were identified from an institutional database of 6259 surgically treated patients with WDTC. Patient and tumor characteristics were analyzed. Disease-specific survival (DSS) and recurrence-free survival (RFS) were calculated using the Kaplan-Meier method.

RESULTS

The pT classification was T1 for 41 and T2 for two patients. All were clinical N0, but 10 pts were pN1a. Using the American Thyroid Association risk stratification system, 9 patients were low-risk and 22 were intermediate-risk. One patient developed local recurrence, and two developed regional lymph node metastases; the 5- and 10-year DSS was 100.0%. The 5- and 10-year RFS was 93.1%.

CONCLUSIONS

Isthmusectomy alone is an acceptable procedure in selected patients with low- and intermediate-risk WDTC limited to the isthmus.

摘要

背景

峡部切除术治疗分化型甲状腺癌(WDTC)存在争议。在本研究中,我们分析了仅接受峡部切除术治疗的WDTC患者的预后。

方法

从一个包含6259例接受手术治疗的WDTC患者的机构数据库中,确定了43例仅接受峡部切除术治疗的患者。分析了患者和肿瘤特征。采用Kaplan-Meier法计算疾病特异性生存率(DSS)和无复发生存率(RFS)。

结果

41例患者的pT分期为T1,2例为T2。所有患者临床均为N0,但10例患者为pN1a。根据美国甲状腺协会风险分层系统,9例患者为低风险,22例为中风险。1例患者发生局部复发,2例发生区域淋巴结转移;5年和10年DSS为100.0%。5年和10年RFS为93.1%。

结论

对于局限于峡部的低风险和中风险WDTC患者,仅行峡部切除术是一种可接受的手术方式。

相似文献

1
Isthmusectomy in selected patients with well-differentiated thyroid carcinoma.对部分高分化甲状腺癌患者行峡部切除术。
Head Neck. 2020 Jan;42(1):43-49. doi: 10.1002/hed.25968. Epub 2019 Oct 7.
2
[Clinical analysis of 27 cases of well differentiated carcinoma of the thyroid isthmus].27例甲状腺峡部高分化癌的临床分析
Zhonghua Zhong Liu Za Zhi. 2013 Nov;35(11):871-4.
3
Thyroid isthmusectomy for well-differentiated thyroid cancer.甲状腺峡部切除术治疗分化型甲状腺癌。
Ann Surg Oncol. 2011 Mar;18(3):767-70. doi: 10.1245/s10434-010-1358-8. Epub 2010 Sep 30.
4
Isthmusectomy for well-differentiated thyroid carcinoma located to the isthmus: A report of two cases and review of the literature.峡部切除术治疗位于峡部的分化型甲状腺癌:两例报告及文献复习。
Medwave. 2021 Nov 29;21(10):e8493. doi: 10.5867/medwave.2021.10.8493.
5
Isthmectomy is effective and sufficient for selected patients with the isthmus-confined solitary papillary thyroid carcinoma.峡部切除术对于局限于峡部的单发甲状腺乳头状癌的特定患者是有效的且充分的。
Asian J Surg. 2022 Sep;45(9):1678-1681. doi: 10.1016/j.asjsur.2021.08.074. Epub 2022 Feb 16.
6
Surgical Outcomes and Efficacy of Isthmusectomy in Single Isthmic Papillary Thyroid Carcinoma: A Preliminary Retrospective Study.峡部切除术治疗单发峡部甲状腺乳头状癌的手术疗效及预后:一项初步回顾性研究。
J Invest Surg. 2021 Oct;34(10):1129-1134. doi: 10.1080/08941939.2020.1749329. Epub 2020 Apr 13.
7
Comparison of Outcomes Following Thyroid Isthmusectomy, Unilateral Thyroid Lobectomy, and Total Thyroidectomy in Patients with Papillary Thyroid Microcarcinoma of the Thyroid Isthmus: A Retrospective Study at a Single Center.甲状腺峡部乳头状微小癌患者行甲状腺峡部切除术、单侧甲状腺叶切除术和全甲状腺切除术的疗效比较:单中心回顾性研究
Med Sci Monit. 2020 Dec 22;26:e927407. doi: 10.12659/MSM.927407.
8
Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.同质管理的pT3分化型甲状腺癌人群中的复发风险。
Langenbecks Arch Surg. 2018 May;403(3):325-332. doi: 10.1007/s00423-018-1657-2. Epub 2018 Feb 14.
9
Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy.甲状腺叶切除术治疗甲状腺内分化良好的恶性肿瘤。
Surgery. 2012 Apr;151(4):571-9. doi: 10.1016/j.surg.2011.08.016. Epub 2011 Oct 14.
10
Long-Term Outcomes of Lateral Neck Dissection in Patients with Recurrent or Persistent Well-Differentiated Thyroid Cancer.复发性或持续性分化型甲状腺癌患者侧颈部清扫术的长期结果。
Thyroid. 2017 Oct;27(10):1291-1299. doi: 10.1089/thy.2017.0203. Epub 2017 Sep 14.

引用本文的文献

1
Thermal ablation for papillary thyroid microcarcinoma in the isthmus: a systematic review and meta-analysis.峡部甲状腺微小乳头状癌的热消融:一项系统评价和荟萃分析
Endocr Connect. 2025 Jul 24;14(7). doi: 10.1530/EC-25-0268. Print 2025 Jul 1.
2
Ultrasound-guided radiofrequency ablation for isthmus papillary thyroid microcarcinoma: a prospective 2 years of follow-up study.超声引导下射频消融治疗峡部甲状腺微小乳头状癌:一项为期2年的前瞻性随访研究。
Updates Surg. 2025 Jan 27. doi: 10.1007/s13304-025-02085-5.
3
Characteristics and risk factors of cervical lymph node metastasis in cN0 papillary thyroid microcarcinoma of the isthmus.

本文引用的文献

1
Using the American Thyroid Association Risk-Stratification System to Refine and Individualize the American Joint Committee on Cancer Eighth Edition Disease-Specific Survival Estimates in Differentiated Thyroid Cancer.利用美国甲状腺协会风险分层系统细化和个体化美国癌症联合委员会第八版分化型甲状腺癌疾病特异性生存估计。
Thyroid. 2018 Oct;28(10):1293-1300. doi: 10.1089/thy.2018.0186. Epub 2018 Aug 2.
2
Reassessment of Differentiated Thyroid Cancer Patients Using the Eighth TNM/AJCC Classification System: A Comparative Study.采用第八版 TNM/AJCC 分类系统对分化型甲状腺癌患者进行再评估:一项比较研究。
Thyroid. 2018 Feb;28(2):201-209. doi: 10.1089/thy.2017.0265. Epub 2018 Jan 22.
3
颈中部微小乳头状甲状腺癌 cN0 患者的颈淋巴结转移特征及其危险因素。
Updates Surg. 2024 Aug;76(4):1413-1423. doi: 10.1007/s13304-024-01760-3. Epub 2024 Mar 26.
4
Total thyroidectomy versus less-than-total thyroidectomy for papillary thyroid carcinoma of isthmus: a systematic review and meta-analysis.甲状腺峡部乳头状癌行甲状腺全切除术与次全切除术的比较:一项系统评价和荟萃分析
Gland Surg. 2023 Nov 24;12(11):1525-1540. doi: 10.21037/gs-23-300. Epub 2023 Nov 16.
5
Implications of isthmic location as a risk factor in papillary thyroid carcinoma.峡部位置作为甲状腺乳头状癌风险因素的意义
Gland Surg. 2023 Jul 31;12(7):952-962. doi: 10.21037/gs-23-56. Epub 2023 Jul 21.
6
Development and validation of nomograms for predicting the risk of central lymph node metastasis of solitary papillary thyroid carcinoma of the isthmus.颈中部孤立性甲状腺乳头状癌中央区淋巴结转移风险预测列线图的建立与验证。
J Cancer Res Clin Oncol. 2023 Nov;149(16):14853-14868. doi: 10.1007/s00432-023-05146-7. Epub 2023 Aug 20.
7
Investigating the impact of tumor location and size on the risk of recurrence for papillary thyroid carcinoma in the isthmus.研究峡部甲状腺乳头状癌肿瘤位置和大小对复发风险的影响。
Cancer Med. 2023 Jun;12(12):13290-13299. doi: 10.1002/cam4.6023. Epub 2023 May 3.
8
Risk prediction for central lymph node metastasis in isolated isthmic papillary thyroid carcinoma by nomogram: A retrospective study from 2010 to 2021.基于列线图的孤立峡部型甲状腺微小乳头状癌中央区淋巴结转移风险预测:一项 2010 年至 2021 年的回顾性研究。
Front Endocrinol (Lausanne). 2023 Jan 17;13:1098204. doi: 10.3389/fendo.2022.1098204. eCollection 2022.
9
Surgical Extent of Central Lymph Node Dissection for Papillary Thyroid Carcinoma Located in the Isthmus: A Propensity Scoring Matched Study.颈中部甲状腺癌行中央区淋巴结清扫术的范围:倾向评分匹配研究。
Front Endocrinol (Lausanne). 2021 Jun 15;12:620147. doi: 10.3389/fendo.2021.620147. eCollection 2021.
10
Comparison of Outcomes Following Thyroid Isthmusectomy, Unilateral Thyroid Lobectomy, and Total Thyroidectomy in Patients with Papillary Thyroid Microcarcinoma of the Thyroid Isthmus: A Retrospective Study at a Single Center.甲状腺峡部乳头状微小癌患者行甲状腺峡部切除术、单侧甲状腺叶切除术和全甲状腺切除术的疗效比较:单中心回顾性研究
Med Sci Monit. 2020 Dec 22;26:e927407. doi: 10.12659/MSM.927407.
The 2017 Bethesda System for Reporting Thyroid Cytopathology.
2017 年甲状腺细胞病理学报告的贝塞斯达系统。
Thyroid. 2017 Nov;27(11):1341-1346. doi: 10.1089/thy.2017.0500.
4
Papillary thyroid carcinoma of the isthmus: Total thyroidectomy or isthmusectomy?峡部甲状腺乳头状癌:行甲状腺全切除术还是峡部切除术?
Am J Surg. 2018 Jul;216(1):135-139. doi: 10.1016/j.amjsurg.2017.09.008. Epub 2017 Sep 19.
5
Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.低危分化型甲状腺癌处理中的争议。
Endocr Rev. 2017 Aug 1;38(4):351-378. doi: 10.1210/er.2017-00067.
6
Lymph node metastasis characteristics of papillary thyroid carcinoma located in the isthmus: A single-center analysis.位于甲状腺峡部的乳头状甲状腺癌的淋巴结转移特征:单中心分析。
Medicine (Baltimore). 2017 Jun;96(24):e7143. doi: 10.1097/MD.0000000000007143.
7
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.1974 - 2013年美国甲状腺癌发病率和死亡率趋势
JAMA. 2017 Apr 4;317(13):1338-1348. doi: 10.1001/jama.2017.2719.
8
Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.甲状腺癌的管理:英国国家多学科指南
J Laryngol Otol. 2016 May;130(S2):S150-S160. doi: 10.1017/S0022215116000578.
9
Surgical procedures for papillary thyroid carcinoma located in the thyroid isthmus: an intention-to-treat analysis.位于甲状腺峡部的乳头状甲状腺癌的外科手术:一项意向性分析。
Onco Targets Ther. 2016 Aug 22;9:5209-16. doi: 10.2147/OTT.S106837. eCollection 2016.
10
Thyroid cancer.甲状腺癌。
Lancet. 2016 Dec 3;388(10061):2783-2795. doi: 10.1016/S0140-6736(16)30172-6. Epub 2016 May 27.